Heart News and Research

RSS

HIPAA privacy rule makes it harder, costlier to do research that improves the quality of medical care

New research reveals a clash between two of the biggest issues in health care today: protecting individual patients' privacy and improving the quality, safety and cost of medical care for all patients.

26 May 2005

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

A post-market analysis of cholesterol-lowering drugs called statins indicates that some of the most serious side effects may be higher in one of the newest drugs, rosuvastatin (Crestor). The drug is the strongest statin available because it has the greatest effect per milligram on low-density lipoprotein ("bad" cholesterol).

26 May 2005

'Brown fat cells' hold clues for possible obesity treatments

Joslin Diabetes Center scientists have discovered a group of genes that govern the genesis of calorie-burning fat cells. This discovery may lead to novel ways to treat obesity in humans.

26 May 2005

Study shows how COX-2 inhibitors lead to heart disease

University of Pennsylvania School of Medicine researchers have found additional evidence that may help explain how selective inhibitors of COX-2 might predispose individuals to heart disease and stroke.

26 May 2005

Patients with metabolic syndrome and moderate calcium levels in the coronary arteries have greater chance of blocked arteries

Conditions such as abdominal obesity, high blood pressure, abnormal cholesterol levels and high blood sugar are problematic enough for people all on their own.

26 May 2005

Statin drugs prescribed for heart disease also reduce the risk of colon cancer

According to new research released this week people taking statin drugs to control the progression of heart disease may be getting the extra benefit of protection from colorectal cancer.

25 May 2005

Brain fatty acid levels linked to depression

A group of researchers from Israel has discovered that rats exhibiting the signs of depression have increased levels of the omega-6 fatty acid, arachidonic acid, in their brains. The details of their findings appear in the June issue of the Journal of Lipid Research, an American Society for Biochemistry and Molecular Biology journal.

25 May 2005

Moderate program of physical exercise helps maintain bone mass in elderly

Debunking the myth that exercising to lose excess body fat, unlike dieting alone, comes at a cost to bone health, researchers at Johns Hopkins have determined that for those age 55 to 75, a moderate program of physical exercise generally maintains bone mass and, in some cases, offers modest improvements.

25 May 2005

Exercise boosts chances of surviving breast cancer

A new study is the first to produce evidence that exercise improves the prospects of beating a malignancy, and proves that being physically active boosts the odds that breast cancer patients will survive the disease.

25 May 2005

Patients approaching the end of life can significantly reduce their depression symptoms and improve their sense of spiritual well-being

"Patients with serious medical conditions frequently suffer psychological, relational, and spiritual distress that is being inadequately addressed by modern health care," writes first author Douglas Miller, M.D., Indiana University School of Medicine professor of medicine, Regenstrief Institute, Inc. research scientist, and associate director of the IU Center for Aging Research.

25 May 2005

Team IDs mechanism for multiplying adult stem cells

While research on human embryonic stem cells gets most of the press, scientists are also investigating the potential therapeutic uses of adult stem cells. Although less controversial, this research faces other difficulties. Adult stem cells are extremely difficult to isolate and multiply in the lab.

24 May 2005

Guidant admits, three years down the line, to a fault with internal heart defibrillator

In a very belated admission Guidant Corp., has now acknowledged that it's internal heart defibrillator has an electrical problem that caused a small fraction of the implanted devices to short-circuit.

24 May 2005

Fetal programming and childhood factors can't be blamed for poor bone health in mid life

This study collected comprehensive information on birth and childhood factors, and has regularly tracked the health of 1000 babies born in May and June 1947 in Newcastle upon Tyne, north eastern England.

24 May 2005

Breastfeeding is as good for children's blood pressure as exercise and dietary salt restriction

The research team assessed the impact of breastfeeding on elements of the metabolic syndrome in over 2000 randomly chosen children from Denmark and Estonia, aged between 9 and 15.

24 May 2005

A diet rich in milk does not increase the risk of heart disease and stroke

The research team asked a representative sample of 764 men to weigh and record every item of food and drink they consumed for seven consecutive days. Just under 90% of the sample (665) produced complete and detailed diaries.

24 May 2005

New cholesterol drug Crestor causes safety concerns

A study by a leading medical journal has concluded that AstraZeneca's controversial drug Crestor produces more than twice as many side effects as other common cholesterol lowering treatments.

24 May 2005

Patients at high risk of stroke may need to continue Warfarin therapy after heart rhythm is controlled

Treatment with warfarin, a medication that prevents blood clotting, may reduce the risk of stroke by more than two-thirds in patients with atrial fibrillation (AF), a condition which places them at high risk of stroke, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 May 2005

Metabolic syndrome prevalent in heart attack patients

Nearly half of heart attack patients also met criteria for metabolic syndrome, putting them at a higher risk for development of heart failure, according to an article in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 May 2005

Within six months, one in three patients fail to take cardiovascular risk-lowering medications as prescribed

Therapy that includes medications to reduce high blood pressure and to lower lipid levels can reduce risk for heart disease, but within six months, more than a third of patients fail to take one or both medications as prescribed, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 May 2005

Heart disease and stroke burden every region of the world leading to increased inequalities in health

Heart disease and stroke are responsible for 17 million deaths each year, represent a major burden of disease in every region of the world and are contributing to an alarming increase in health inequalities, both within and between countries.

23 May 2005

Heart News and Research

HIPAA privacy rule makes it harder, costlier to do research that improves the quality of medical care

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

'Brown fat cells' hold clues for possible obesity treatments

Study shows how COX-2 inhibitors lead to heart disease

Patients with metabolic syndrome and moderate calcium levels in the coronary arteries have greater chance of blocked arteries

Statin drugs prescribed for heart disease also reduce the risk of colon cancer

Brain fatty acid levels linked to depression

Moderate program of physical exercise helps maintain bone mass in elderly

Exercise boosts chances of surviving breast cancer

Patients approaching the end of life can significantly reduce their depression symptoms and improve their sense of spiritual well-being

Team IDs mechanism for multiplying adult stem cells

Guidant admits, three years down the line, to a fault with internal heart defibrillator

Fetal programming and childhood factors can't be blamed for poor bone health in mid life

Breastfeeding is as good for children's blood pressure as exercise and dietary salt restriction

A diet rich in milk does not increase the risk of heart disease and stroke

New cholesterol drug Crestor causes safety concerns

Patients at high risk of stroke may need to continue Warfarin therapy after heart rhythm is controlled

Metabolic syndrome prevalent in heart attack patients

Within six months, one in three patients fail to take cardiovascular risk-lowering medications as prescribed

Heart disease and stroke burden every region of the world leading to increased inequalities in health

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News